Kouji Izumi

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 43

Top Topics

Radical Prostatectomy

Diffusion Weighted

Renal Cell Carcinoma

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Nobumichi Tanaka, Kouji Izumi, Yasushi Nakai, Takashi Shima, Yuki Kato, Koji Mita, Manabu Kamiyama, Shogo Inoue, Seiji Hoshi, Takehiko Okamura, Yuko Yoshio, Hideki Enokida, Ippei Chikazawa, Noriyasu Kawai, Kohei Hashimoto, Takashi Fukagai, Kazuyoshi Shigehara, Shizuko Takahara, Atsushi Mizokami
Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCa. The Prostate (2024)
Hiroshi Kano, Yoshifumi Kadono, Renato Naito, Tomoyuki Makino, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kouji Izumi, Atsushi Mizokami
Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy. Cancers 16 (7) (2024)
Hiroshi Kano, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Tomoyuki Makino, Renato Naito, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Kazuyoshi Shigehara, Takahiro Nohara, Atsushi Mizokami
Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate Cancer. Biomedicines 12 (2) (2024)
Hiroshi Kano, Yoshifumi Kadono, Renato Naito, Tomoyuki Makino, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kouji Izumi, Atsushi Mizokami
Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy. Cancers 16 (7) (2024)
Hiroshi Kano, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Tomoyuki Makino, Renato Naito, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Kazuyoshi Shigehara, Takahiro Nohara, Atsushi Mizokami
Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate Cancer. Biomedicines 12 (2) (2024)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (2) (2023)
Kouji Izumi
Editorial for the Special Issue on High-Risk Localized and Locally Advanced Prostate Cancer. Cancers 15 (12) (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (2) (2023)
Yuki Kato, Kazuyoshi Shigehara, Tomomi Nakagawa, Shohei Kawaguchi, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Relation between athletic club affiliation from school age and future serum free testosterone levels in Japan: A cross-sectional study. Health science reports 6 (8) (2023)
Yoshifumi Kadono, Takahiro Nohara, Shohei Kawaguchi, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Masashi Iijima, Kazuyoshi Shigehara, Kouji Izumi, Atsushi Mizokami
Postoperative functional and cancer control evaluation of conventional and Retzius-sparing robot-assisted radical prostatectomy: Comparison of selected cases by propensity score matching. The Prostate (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (2) (2023)
Kouji Izumi
Editorial for the Special Issue on High-Risk Localized and Locally Advanced Prostate Cancer. Cancers 15 (12) (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Atsushi Mizokami
Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (6) (2023)
Yoshifumi Kadono, Hiroyuki Konaka, Takahiro Nohara, Kouji Izumi, Satoshi Anai, Kiyohide Fujimoto, Tomoyuki Koguchi, Kei Ishibashi, Noriyasu Kawai, Keita Nakane, Akinori Iba, Naoya Masumori, Shizuko Takahara, Atsushi Mizokami
Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study. Cancers 15 (10) (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Atsushi Mizokami
Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (6) (2023)
Tomomi Nakagawa, Kazuyoshi Shigehara, Yuki Kato, Shohei Kawaguchi, Hiroki Nakata, Taito Nakano, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples. Journal of medical virology (2022)
Kazuyoshi Shigehara, Yuki Kato, Kouji Izumi, Atsushi Mizokami
Relationship between Testosterone and Sarcopenia in Older-Adult Men: A Narrative Review. Journal of clinical medicine 11 (20) (2022)
Shohei Kawaguchi, Kouji Izumi, Renato Naito, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Takahiro Nohara, Kazuyoshi Shigehara, Kotaro Yoshida, Yoshifumi Kadono, Atsushi Mizokami
Comparison of Clinical Outcomes between Robot-Assisted Partial Nephrectomy and Cryoablation in Elderly Patients with Renal Cancer. Cancers 14 (23) (2022)
Shohei Kawaguchi, Kouji Izumi, Renato Naito, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Takahiro Nohara, Kazuyoshi Shigehara, Kotaro Yoshida, Yoshifumi Kadono, Atsushi Mizokami
Comparison of Clinical Outcomes between Robot-Assisted Partial Nephrectomy and Cryoablation in Elderly Patients with Renal Cancer. Cancers 14 (23) (2022)
Tomoyuki Makino, Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
Epidemiology and Prevention of Renal Cell Carcinoma. Cancers 14 (16) (2022)
Hiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Takafumi Shimada, Hiroshi Kano, Tomoyuki Makino, Renato Naito, Suguru Kadomoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer. Biomedicines 10 (10) (2022)
Hiroshi Kano, Kouji Izumi, Kaoru Hiratsuka, Ren Toriumi, Ryunosuke Nakagawa, Shuhei Aoyama, Taiki Kamijima, Takafumi Shimada, Renato Naito, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Yohei Saito, Kyoko Nakagawa-Goto, Kazuaki Yoshioka, Hiroki Nakata, Wen-Jye Lin, Atsushi Mizokami
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis. Cancer science (2022)
Yoshifumi Kadono, Takahiro Nohara, Shohei Kawaguchi, Hiroaki Iwamoto, Hiroshi Yaegashi, Kazuyoshi Shigehara, Kouji Izumi, Atsushi Mizokami
Impact of Pelvic Anatomical Changes Caused by Radical Prostatectomy. Cancers 14 (13) (2022)
Ren Toriumi, Hiroshi Yaegashi, Suguru Kadomoto, Hiroaki Iwamoto, Masashi Iijima, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Decreased febrile neutropenia during inpatient chemotherapy for urologic cancer during coronavirus disease 2019 pandemic. Cancer science (2022)
Shohei Kawaguchi, Kouji Izumi, Renato Naito, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Takahiro Nohara, Kazuyoshi Shigehara, Kotaro Yoshida, Yoshifumi Kadono, Atsushi Mizokami
Comparison of Clinical Outcomes between Robot-Assisted Partial Nephrectomy and Cryoablation in Elderly Patients with Renal Cancer. Cancers 14 (23) (2022)
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
Macrophage Polarity and Disease Control. International journal of molecular sciences 23 (1) (2021)
Tomoyuki Makino, Kouji Izumi, Atsushi Mizokami
Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment. Biomedicines 9 (4) (2021)
Kazuyoshi Shigehara, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Testosterone and Bone Health in Men: A Narrative Review. Journal of clinical medicine 10 (3) (2021)
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment. International journal of molecular sciences 22 (16) (2021)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Atsushi Mizokami
Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer. Cancers 13 (17) (2021)
Kouji Izumi, Hiroaki Iwamoto, Hiroshi Yaegashi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Shigeki Nanjo, Tadaaki Yamada, Koshiro Ohtsubo, Seiji Yano, Atsushi Mizokami
Androgen replacement therapy for cancer-related symptoms in male: result of prospective randomized trial (ARTFORM study). Journal of cachexia, sarcopenia and muscle 12 (4) (2021)
Renato Naito, Hiroshi Kano, Takashi Shimada, Tomoyuki Makino, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Kouji Izumi, Yoshifumi Kadono, Hiroki Nakata, Yohei Saito, Masuo Goto, Kyoko Nakagawa-Goto, Atsushi Mizokami
A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells. The Prostate 81 (5) (2021)
Yuki Kato, Kazuyoshi Shigehara, Shohei Kawaguchi, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Efficacy of testosterone replacement therapy on pain in hypogonadal men with chronic pain syndrome: A subanalysis of a prospective randomised controlled study in Japan (EARTH study). Andrologia 52 (9) (2020)
Hiroaki Iwamoto, Kouji Izumi, Atsushi Mizokami
Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis? International journal of molecular sciences 21 (23) (2020)
Hiroaki Iwamoto, Kouji Izumi, Takashi Shimada, Hiroshi Kano, Suguru Kadomoto, Tomoyuki Makino, Renato Naito, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
Androgen receptor signaling-targeted therapy and taxane chemotherapy induce visceral metastasis in castration-resistant prostate cancer. The Prostate 81 (1) (2020)
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
The CCL20-CCR6 Axis in Cancer Progression. International journal of molecular sciences 21 (15) (2020)
Suguru Kadomoto, Kazuyoshi Shigehara, Hiroaki Iwamoto, Hiroshi Yaegashi, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review. The world journal of men's health 38 (1) (2019)
Suguru Kadomoto, Kouji Izumi, Kaoru Hiratsuka, Taito Nakano, Renato Naito, Tomoyuki Makino, Hiroaki Iwamoto, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Hiroki Nakata, Yohei Saito, Kyoko Nakagawa Goto, Atsushi Mizokami
Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis. Cancers 12 (1) (2019)
Kouji Izumi, Atsushi Mizokami
Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells. Journal of clinical medicine 8 (3) (2019)
Ariunbold Natsagdorj, Kouji Izumi, Kaoru Hiratsuka, Kazuaki Machioka, Hiroaki Iwamoto, Renato Naito, Tomoyuki Makino, Suguru Kadomoto, Kazuyoshi Shigehara, Yoshifumi Kadono, Wen-Jye Lin, Aerken Maolake, Atsushi Mizokami
CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells. Cancer science 110 (1) (2018)
Satoko Urata, Kouji Izumi, Kaoru Hiratsuka, Aerken Maolake, Ariunbold Natsagdorj, Kazuyoshi Shigehara, Hiroaki Iwamoto, Suguru Kadomoto, Tomoyuki Makino, Renato Naito, Yoshifumi Kadono, Wen-Jye Lin, Guzailinuer Wufuer, Kazutaka Narimoto, Atsushi Mizokami
C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment. Cancer science 109 (3) (2018)
Hiroaki Iwamoto, Kouji Izumi, Ariunbold Natsagdorj, Renato Naito, Tomoyuki Makino, Suguru Kadomoto, Kaoru Hiratsuka, Kazuyoshi Shigehara, Yoshifumi Kadono, Kazutaka Narimoto, Yohei Saito, Kyoko Nakagawa-Goto, Atsushi Mizokami
Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells. The Prostate 79 (5) (2018)
Aerken Maolake, Kouji Izumi, Ariunbold Natsagdorj, Hiroaki Iwamoto, Suguru Kadomoto, Tomoyuki Makino, Renato Naito, Kazuyoshi Shigehara, Yoshifumi Kadono, Kaoru Hiratsuka, Guzailinuer Wufuer, Kent L Nastiuk, Atsushi Mizokami
Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation. Cancer science 109 (5) (2018)